These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 37757992)
1. Mechanism of Sophorae Flavescentis Radix (Kushen) in treating NSCLC: Insights from miRNA-mRNA network analysis. Li J; Huang Y; Xu J; Zuo H; Tang Y; Huang HY; Chen J; Lin YC; Huang HD J Ethnopharmacol; 2024 Jan; 319(Pt 3):117232. PubMed ID: 37757992 [TBL] [Abstract][Full Text] [Related]
2. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
4. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway. Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514 [No Abstract] [Full Text] [Related]
5. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer. Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857 [TBL] [Abstract][Full Text] [Related]
6. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168 [TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
8. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer. Jin X; Guan Y; Zhang Z; Wang H BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382 [TBL] [Abstract][Full Text] [Related]
9. MiR-181a reduces radiosensitivity of non-small-cell lung cancer via inhibiting PTEN. Chen Y; Liao W; Yuan A; Xu H; Yuan R; Cao J Panminerva Med; 2022 Sep; 64(3):374-383. PubMed ID: 32506887 [TBL] [Abstract][Full Text] [Related]
10. Investigating herb-herb interactions: the potential attenuated toxicity mechanism of the combined use of Glycyrrhizae radix et rhizoma (Gancao) and Sophorae flavescentis radix (Kushen). Shi L; Tang X; Dang X; Wang Q; Wang X; He P; Wang Q; Liu L; Liu X; Zhang Y J Ethnopharmacol; 2015 May; 165():243-50. PubMed ID: 25701755 [TBL] [Abstract][Full Text] [Related]
11. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
12. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor. Zhao FY; Han J; Chen XW; Wang J; Wang XD; Sun JG; Chen ZT Int J Mol Med; 2016 Jul; 38(1):183-91. PubMed ID: 27177336 [TBL] [Abstract][Full Text] [Related]
13. miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer. Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y Pathol Res Pract; 2018 May; 214(5):700-705. PubMed ID: 29567332 [TBL] [Abstract][Full Text] [Related]
14. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion. Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665 [TBL] [Abstract][Full Text] [Related]
15. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. Liu B; Wang R; Liu H Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989 [TBL] [Abstract][Full Text] [Related]
16. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92b acts as an oncogene by targeting PTEN/AKT in NSCLC. Guo JH; Fang HY; Yang JM; Liu SL; Yao QH; Fan YJ; Zhao M; Liu F; Zhang QW; Gao FH Cell Biochem Funct; 2020 Dec; 38(8):1100-1110. PubMed ID: 32627866 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN. Li H; Huhe M; Lou J Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670 [TBL] [Abstract][Full Text] [Related]
20. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer. Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]